In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Kariyama
R
R
Kumon
H
H
Chow
L
L
Zervos
M J
MJ
Takata
T
T
Tabata
M
M
Chow
J W
JW
D000617:Aminoglycosides; D000667:Ampicillin / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003982:Dibekacin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D013293:Enterococcus faecalis / Q000187:drug effects*; D016984:Enterococcus faecium / Q000187:drug effects; D005839:Gentamicins / Q000494:pharmacology; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D003982:Dibekacin; D000667:Ampicillin; C031986:arbekacin